China Approves Its Homegrown COVID-19 Vaccine For Widespread Use
The state-owned Sinopharm says its vaccine has a 79% efficacy rate — surpassing the widely accepted standard of 50% efficacy.
Full Article
China Approves Its Homegrown COVID-19 Vaccine For Widespread Use
NPR
0 shares
1 views
You might like
Related news coverage
China OKs 1st homegrown coronavirus vaccine as virus surges globally
Upworthy
China authorized its first homegrown COVID-19 vaccine for general use Thursday, adding another shot that could see wide use in..
Advertisement
More coverage
Competition Is What States Make Of It: A US Strategy Toward China – Analysis
Eurasia Review
By Kaleb J. Redden*
China today represents the “most consequential long-term challenge we face as a nation.”2 While..
